IL15 and neoplasm: To further link tonic signaling score with antitumor activity, we analyzed the single cell RNA-seq dataset from CAR-T clinical trials in liver tumors 64, in which IL-15–engineered CAR-T cells displayed enhanced expansion, persistence, and tumor control.